EPISODE · Jul 5, 2026 · 8 MIN
解读: 美国肥胖协会最新发布的肥胖症药物治疗指南
from 消化肝病前沿资讯
本期播客解读美国肥胖协会最新发布的肥胖症药物治疗指南，打破“肥胖是自控问题”的旧认知，明确肥胖为慢性病。内容涵盖用药无需先试生活方式干预的新规、主流减重药物效果、并发症改善证据、用药注意事项及长期管理策略，帮助听众全面了解肥胖治疗的新方向。00:06肥胖被定义为慢性病00:35用药无需先试生活干预01:25主流药物减重效果解析02:12司美格鲁肽等新药数据02:59开药前需做药物审查03:46减重目标为改善并发症04:25减重改善心衰等心血管病05:00药物可改善多类合并症05:44GLP-1药物副作用应对06:26用药期营养与饮水建议07:03肥胖需长期用药防反弹07:55治疗进入综合干预时代
Embed this episode
Ready to play
解读: 美国肥胖协会最新发布的肥胖症药物治疗指南
0:00
8:06
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 8 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on July 5, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!